Hung Tseng to Vaccines, Conjugate
This is a "connection" page, showing publications Hung Tseng has written about Vaccines, Conjugate.
Connection Strength
0.835
-
Real-world evidence of quadrivalent meningococcal conjugate vaccine safety in the United States: a systematic review. Hum Vaccin Immunother. 2021 05 04; 17(5):1432-1441.
Score: 0.184
-
Safety of MenACWY-CRM vaccine exposure during pregnancy. Vaccine. 2020 03 10; 38(12):2683-2690.
Score: 0.173
-
Safety of quadrivalent meningococcal conjugate vaccine in infants and toddlers 2 to 23-months old. Vaccine. 2020 01 10; 38(2):228-234.
Score: 0.170
-
Safety of Quadrivalent Meningococcal Conjugate Vaccine in Children 2-10 Years. Pediatr Infect Dis J. 2017 Nov; 36(11):1087-1092.
Score: 0.148
-
Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children. Vaccine. 2013 May 24; 31(22):2578-83.
Score: 0.108
-
Kawasaki Disease Following the 13-valent Pneumococcal Conjugate Vaccine and Rotavirus Vaccines. Pediatrics. 2022 12 01; 150(6).
Score: 0.053